Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain

@article{Nyrop2007CostsOH,
  title={Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain},
  author={K. Nyrop and O. Palsson and R. Levy and M. Korff and A. Feld and M. Turner and W. Whitehead},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2007},
  volume={26}
}
Aim To provide estimates of actual costs to deliver health care to patients with functional bowel disorders, and to assess the cost impact of symptom severity, recency of onset, and satisfaction with treatment. 
Review article: the economic impact of the irritable bowel syndrome
TLDR
A large number of people worldwide have IBS, and it has substantial impact on patients' quality of life (QoL) and is associated with considerable healthcare resource use. Expand
Home-Based Treatment for Chronic Constipation
TLDR
Careful assessment by obtaining a thorough history and physical examination with limited indicated diagnostic testing is important to identify potential underlying etiologies and to treat effectively. Expand
The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials
Few clinical trials in chronic idiopathic constipation (CIC) patients have evaluated abdominal symptom severity and whether CIC patients with abdominal symptoms respond similarly to patients withExpand
Functional gastrointestinal disorders in children and adolescents: Knowledge, practice and attitudes of Australian paediatricians
To investigate paediatricians' understanding of, and approaches to, the diagnosis and treatment of functional abdominal pain (FAP) and irritable bowel syndrome (IBS) in children.
Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients
TLDR
Gut‐focused hypnotherapy improves the symptoms of irritable bowel syndrome (IBS) with benefits being sustained for many years and relatively small numbers in published studies. Expand
A gap in our understanding: chronic constipation and its comorbid conditions.
  • N. Talley, K. Lasch, C. Baum
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009
TLDR
There are considerable clinical consequences associated with constipation and realization of the disease risks associated with chronic constipation may provide the impetus needed to direct new research, and shift attention on the part of patients and practitioners to methods for preventing significant and potentially costly comorbid medical problems. Expand
Original article Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome
TLDR
The aim of this study was to assess the effect of IBS-C on health-related quality of life (HRQOL), work productivity and activity impairment, and health care resource use. Expand
Chronic constipation: overview and challenges
TLDR
The purpose of this supplement is to address critically the reasons for the current lack of understanding of the pathophysiology of constipation and to propose avenues of future research to address these deficiencies. Expand
Epidemiology and burden of chronic constipation.
TLDR
An increase in the prevalence of constipation is expected in the years to come, with the associated impact on quality of life and socioeconomic burden. Expand
Epidemiology and burden of chronic constipation
TLDR
An increase in the prevalence of constipation is expected in the years to come, with the associated impact on quality of life and socioeconomic burden. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
The usual medical care for irritable bowel syndrome
Aims : To determine what constitutes usual medical care for irritable bowel syndrome, which patient characteristics influence choice of treatment and how satisfied patients are with care.
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress
Background: The clinical assessment and investigation of irritable bowel syndrome would be greatly facilitated by the introduction of a simple, easy to use severity scoring system. Such a system,Expand
Costs of care for irritable bowel syndrome patients in a health maintenance organization
TLDR
Patients with IBS show sustained increases in health care costs relative to population controls for both lower GI services and care unrelated to lower GI problems, however, the majority of the excess resulted from medical care not directly related to lowerGI problems. Expand
The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus
TLDR
This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion. Expand
Design of treatment trials for functional gastrointestinal disorders
Until recently many clinical trials of functional gastrointestinal disorders (FGIDs) suffered from important weaknesses in trial design, study execution, and data analysis. This makes it difficult toExpand
The burden of selected digestive diseases in the United States.
TLDR
The most prevalent diseases were non-food-borne gastroenteritis, food-borne illness, gastroesophageal reflux disease, and irritable bowel syndrome, followed by gallbladder disease, which had the highest annual direct costs in the United States. Expand
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
TLDR
The IBS-QOL is responsive to treatment in a referral-based clinical population of patients with functional bowel disorders, and there was a significant correlation between change scores on the IBS -QOL and the other measures of treatment effect. Expand
Rome II: the Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: a Multinational Consensus
TLDR
The Rome process has had a major impact, and Rome criteria are now used for the entry into most clinical trials, so that classifications must of necessity be symptom based. Expand
The epidemiology of irritable bowel syndrome in North America: a systematic review
TLDR
Approximately 30 million people in North America meet the diagnostic criteria for IBS, however, data about the natural history of IBS is quite sparse and renewed efforts should be focused at developing appropriately designed trials of the epidemiology of Ibs. Expand
Epidemiology of irritable bowel syndrome in the United States.
TLDR
The data support the impression that irritable bowel syndrome is a prevalent condition in the United States with significant impact on health care and large-scale, population-based surveys using standard criteria are needed to estimate the true extent. Expand
...
1
2
3
...